A RANDOMIZED, DOUBLE-BLIND,DOUBLE-DUMMY, ACTIVE-COMPARATOR,MULTICENTER STUDY TO EVALUATE THEEFFICACY AND SAFETY OF RITUXIMAB VERSUSMMF IN PATIENTS WITH PEMPHIGUS VULGARIS
Sponsor: Genentech
Protocol number: WA29330
Projected enrollment dates: February 2015
Official study title: A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE-COMPARATOR, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RITUXIMAB VERSUS MMF IN PATIENTS WITH PEMPHIGUS VULGARIS
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/not yet